BR112022001729A2 - Peptídeo ou um sal farmacêutica ou cosmeticamente aceitável do mesmo, composição farmacêutica ou cosmética, e, composições despigmentante e pigmentante - Google Patents

Peptídeo ou um sal farmacêutica ou cosmeticamente aceitável do mesmo, composição farmacêutica ou cosmética, e, composições despigmentante e pigmentante

Info

Publication number
BR112022001729A2
BR112022001729A2 BR112022001729A BR112022001729A BR112022001729A2 BR 112022001729 A2 BR112022001729 A2 BR 112022001729A2 BR 112022001729 A BR112022001729 A BR 112022001729A BR 112022001729 A BR112022001729 A BR 112022001729A BR 112022001729 A2 BR112022001729 A2 BR 112022001729A2
Authority
BR
Brazil
Prior art keywords
depigmenting
peptide
pharmaceutically
pharmaceutical
acceptable salt
Prior art date
Application number
BR112022001729A
Other languages
English (en)
Portuguese (pt)
Inventor
Laura Nevola
Esteban Martín Santiago
Original Assignee
Idp Discovery Pharma S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idp Discovery Pharma S L filed Critical Idp Discovery Pharma S L
Publication of BR112022001729A2 publication Critical patent/BR112022001729A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/04—Preparations for care of the skin for chemically tanning the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
BR112022001729A 2019-08-02 2020-07-31 Peptídeo ou um sal farmacêutica ou cosmeticamente aceitável do mesmo, composição farmacêutica ou cosmética, e, composições despigmentante e pigmentante BR112022001729A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19382674 2019-08-02
PCT/EP2020/071629 WO2021023646A1 (en) 2019-08-02 2020-07-31 Melanocyte-regulating peptides

Publications (1)

Publication Number Publication Date
BR112022001729A2 true BR112022001729A2 (pt) 2022-04-12

Family

ID=67658460

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022001729A BR112022001729A2 (pt) 2019-08-02 2020-07-31 Peptídeo ou um sal farmacêutica ou cosmeticamente aceitável do mesmo, composição farmacêutica ou cosmética, e, composições despigmentante e pigmentante

Country Status (14)

Country Link
US (1) US12492225B2 (https=)
EP (1) EP4007563A1 (https=)
JP (2) JP2022542512A (https=)
KR (1) KR20220041094A (https=)
CN (1) CN114245800A (https=)
AR (1) AR119529A1 (https=)
AU (1) AU2020325636A1 (https=)
BR (1) BR112022001729A2 (https=)
CA (1) CA3148785A1 (https=)
CL (1) CL2022000208A1 (https=)
IL (1) IL290019B2 (https=)
MX (1) MX2022001114A (https=)
TW (1) TWI889695B (https=)
WO (1) WO2021023646A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116120401B (zh) * 2023-03-22 2025-09-30 中国科学院昆明动物研究所 一种抗黑色素瘤活性多肽kw13、药物及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0201863D0 (en) * 2002-06-18 2002-06-18 Cepep Ab Cell penetrating peptides
US20060014712A1 (en) * 2004-05-30 2006-01-19 Cemines, Inc. Controlled delivery of therapeutic compounds
CN106011233A (zh) * 2010-08-13 2016-10-12 莫尔豪斯医学院 中风的生物标记
DK3430031T3 (da) * 2016-03-15 2022-01-17 Idp Discovery Pharma S L Peptider med anti-kræftaktivitet
AU2018311130A1 (en) * 2017-08-02 2020-02-20 Idp Discovery Pharma, S.L. Anticancer peptides
US20210231663A1 (en) * 2017-12-12 2021-07-29 Oncimmune Germany Gmbh Melanoma checkpoint inhibitor detection and treatment

Also Published As

Publication number Publication date
CL2022000208A1 (es) 2022-09-09
IL290019A (en) 2022-03-01
TW202120117A (zh) 2021-06-01
CA3148785A1 (en) 2021-02-11
TWI889695B (zh) 2025-07-11
AR119529A1 (es) 2021-12-22
JP2025131623A (ja) 2025-09-09
US20230312649A1 (en) 2023-10-05
KR20220041094A (ko) 2022-03-31
AU2020325636A1 (en) 2022-02-10
IL290019B1 (en) 2025-09-01
JP2022542512A (ja) 2022-10-04
MX2022001114A (es) 2022-05-03
WO2021023646A1 (en) 2021-02-11
US12492225B2 (en) 2025-12-09
IL290019B2 (en) 2026-01-01
CN114245800A (zh) 2022-03-25
EP4007563A1 (en) 2022-06-08

Similar Documents

Publication Publication Date Title
EP4349360A3 (en) Peptide exhibiting wrinkle-improving activity and uses thereof
Jan et al. Fibromodulin: A regulatory molecule maintaining cellular architecture for normal cellular function
ATE254448T1 (de) Kosmetische oder dermatologische zusammensetzung, enthaltend zumindest ein natürliches oder rekombinantes seidenprotein von arachniden oder ein analoges protein
MX2019006515A (es) Composiciones que comprenden peptido wkdeagkplvk.
PH12012500756A1 (en) Peptides used in the treatment and/or care of the skin, mucous membranes and/or hair and its use in cosmetic or pharmaceutical compositions
WO2003064449A3 (en) Bioactive keratin peptides
CA2596597A1 (en) Method for stimulation collagen synthesis and/or kgf expression
BR112012004731B8 (pt) peptídeo derivado de wnt10 e composição tópica para tratamento ou prevenção de perda de cabelo
WO2010085039A2 (ko) 노긴―유래 펩타이드 및 그의 용도
EA201990885A1 (ru) Композиции, содержащие короткие пептиды, полученные из pedf, и их применение
KR102077983B1 (ko) 피부 주름 개선 및 미백용 조성물
ATE355073T1 (de) Synergistische kombination von seidenproteinen
DE60138558D1 (de) Peptid aus hsp70 welches nk zellaktivtät stimuliert und seine verwendung
EP4621067A3 (en) Recombinant modified fibroblast growth factors and therapeutic uses thereof
BR112022010786A2 (pt) Métodos de tratamento usando proteínas de ligação a ilt7
EP3998276A3 (en) Growth promoting peptides and uses thereof
DE69900756D1 (de) Verwendung von hmg proteinen zur herstellung von arzneimitteln mit zytotoxischer wirkung
BR112022001729A2 (pt) Peptídeo ou um sal farmacêutica ou cosmeticamente aceitável do mesmo, composição farmacêutica ou cosmética, e, composições despigmentante e pigmentante
MX2022008748A (es) Administración oral de péptidos.
BR112022005782A2 (pt) Proteína galectina 9 estabilizada recombinante, vetor recombinante, transformante, composição farmacêutica para prevenção ou tratamento de uma doença óssea, alimento funcional de saúde para prevenção ou melhora de uma doença óssea, e, uso de uma proteína galectina 9 estabilizada recombinante
MX2025009372A (es) Proteinas/peptidos de fusion, metodos y usos de los mismos
MX2018011082A (es) Péptido o aminoácido n-lipoico, derivados y sus usos.
KR20140089295A (ko) 피부 노화 개선용 조성물
ATE505199T1 (de) Pharmazeutische, kosmetische oder therapeutische zusammensetzungen enthaltend peptide mit dem motiv arg-gly-ser
ES2110057T3 (es) Composicion medicinal que contiene tcf-ii.

Legal Events

Date Code Title Description
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]